Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from FOPE S.p.A. ( (IT:FPE) ).
FOPE has announced the exercise of 20,000 rights under its 2025–2027 stock grant plan for employees, resulting in the issue of 20,000 new ordinary shares and a free share capital increase of €20,000, raising the company’s share capital to €5,419,608. The move, funded via the “Riserva Straordinaria” reserve, formalizes a modest dilution to support employee incentivization and aligns staff interests with those of shareholders; the company will update its Articles of Association and complete the required corporate and registry filings to reflect the new capital structure.
The most recent analyst rating on (IT:FPE) stock is a Buy with a EUR44.00 price target. To see the full list of analyst forecasts on FOPE S.p.A. stock, see the IT:FPE Stock Forecast page.
More about FOPE S.p.A.
FOPE S.p.A. is a historic Italian goldsmith founded in Vicenza in 1929, operating in the high-end jewellery sector and listed on Euronext Growth Milan. With around 75 employees and about 90% of its revenue generated abroad, the company focuses on the international luxury market through a network of over 700 carefully selected multi-brand jewellery retailers and a small portfolio of flagship boutiques in Venice, London and Tokyo. FOPE’s business model combines in-house, highly automated and standardized production in Vicenza with proprietary technologies, emphasizing product quality, Italian craftsmanship, recognizable design and long-term client relationships, while adhering to sustainability and responsible sourcing standards such as TF certification and membership in the Responsible Jewellery Council.
Average Trading Volume: 1,308
Technical Sentiment Signal: Buy
Current Market Cap: €211.7M
For a thorough assessment of FPE stock, go to TipRanks’ Stock Analysis page.

